Meghan C. Thompson, MD¹, John N. Allan, MD², Kavita Sail, PhD^3*, Beenish S. Manzoor, PhD, MPH^3*, Jeffrey J. Pu, MD, PhD⁴, Paul M. Barr, MD⁵, Catherine C. Coombs, MD⁶, Stephen J. Schuster, MD⁷, Alan Skarbnik, MD⁸, Joanna M Rhodes, MD⁹, Jacqueline C. Barrientos, MD⁹, Lindsey E Roeker, MD¹, Lori A. Leslie, MD¹⁰, Manali Kamdar, MD¹¹, Michael Y. Choi, MD¹², Martin Simkovic, MD, PhD^13*, Frederick Lansigan, MD¹⁴, Brittany Jane Hale, MD^14*, Andrew D Zelenetz, MD, PhD¹, Alison J. Moskowitz, MD¹, Kurt S. Bantilan, MPH^1*, Celina J. Komari, BS^1*, Andre H. Goy, MD¹⁰, Tatyana A. Feldman, MD¹⁰, Richard R. Furman, MD² and Anthony R. Mato, MD¹

¹Memorial Sloan Kettering Cancer Center, New York, NY
²Weill Cornell Medicine, New York, NY
³AbbVie, Inc., North Chicago, IL
⁴SUNY Upstate Medical University Cancer Center, Syracuse, NY
⁵Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY
⁶Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC
⁷University of Pennsylvania, Philadelphia, PA
⁸Novant Health, Charlotte, NC
⁹Northwell Health Cancer Institute, Lake Success, NY
¹⁰Hackensack University Medical Center, Hackensack, NJ
¹¹Division of Hematology, Hematologic Malignancies and Stem Cell Transplantation, University of Colorado Cancer Center, Denver, CO
¹²University of California-San Diego, San Diego, CA
¹³University Hospital Hradec Kralove, Charles University, Hradec Kralove, Czech Republic
¹⁴Dartmouth-Hitchcock Medical Center, Lebanon, NH

Paul M. Barr, MD¹, Shuo Ma, MD, PhD², Clive S. Zent, MD¹, Andrea M. Baran, MS^1*, Andrew Bui^1*, Philip J Meacham, PhD^1*, Ashley Morrison, RN^3*, Kelsey Holkovic, RN^3*, Jane L. Liesveld, MD¹, Deborah A Mulford, MD^1*, Peter Sportelli, BS ⁴, Hari P. Miskin, MSc^4*, Michael S. Weiss^4*, Jonathan W. Friedberg, MD, MSSc¹ and Brian T. Hill, MD³

¹Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY
²Division of Hematology and Oncology, Northwestern University Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center, Chicago, IL
³Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
⁴TG Therapeutics, Inc., New York, NY

Nitin Jain, MD¹, Michael J. Keating, MBBS², Philip A. Thompson, MB, MS¹, Alessandra Ferrajoli, MD¹, Jan A. Burger, MD, PhD¹, Gautam Borthakur, MD¹, Koichi Takahashi, MD, PhD¹, Zeev E. Estrov, MD¹, Koji Sasaki, MD¹, Nathan H Fowler, MD³, Tapan M. Kadia, MD¹, Marina Konopleva, MD, PhD⁴, Yesid Alvarado, MD⁵, Musa Yilmaz, MD¹, Courtney D. DiNardo, MD, MSc¹, Prithviraj Bose, MD¹, Maro Ohanian, DO^1*, Naveen Pemmaraju, MD¹, Elias Jabbour, MD¹, Rashmi Kanagal-Shamanna, MD⁶, Keyur Patel, MD, PhD^7*, Wei Wang, MD, PhD^6*, Jeffrey L. Jorgensen, MD, PhD^6*, Sa A Wang, MD^6*, Naveen Garg, MD^8*, Xuemei Wang, MS^9*, Chongjuan Wei, PhD^1*, Nichole Cruz, RN^1*, Ana Ayala, RN^2*, William Plunkett, PhD¹⁰, Hagop M. Kantarjian, MD¹, Varsha Gandhi, PhD¹⁰ and William G. Wierda, MD, PhD¹

¹Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX
³Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, TX
⁵Department of Leukemia, MD Anderson Cancer Center, Houston, TX
⁶Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
⁷Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX
⁸Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX
⁹Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX
¹⁰Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX

Rosemary Anne Harrup^1*, Carolyn Owen, MD FRCPC², James D'Rozario^3*, Tadeusz Robak, MD PhD⁴, Arnon P. Kater^5*, Marco Montillo⁶, Javier de la Serna^7*, Marek Trněný, MD⁸, Su Young Kim^9*, Edward Bataillard^10*, Marcus Lefebure^10*, Michelle Boyer^10* and John F. Seymour, MBBS¹¹

¹Royal Hobart Hospital, Tasmania, Australia
²University of Calgary, Calgary, Canada
³The John Curtin School of Medical Research, Australian National University, Canberra, Australia
⁴Medical University of Lodz, Copernicus Memorial Hospital, Lodz, Poland
⁵Cancer Center Amsterdam, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands
⁶Department of Hematology, Niguarda Cancer Center, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy
⁷Hospital Universitario 12 de Octubre, Madrid, Spain
⁸1st Department of Medicine, 1st Faculty of Medicine, Charles University, General Hospital, Prague, Czech Republic
⁹AbbVie Inc., North Chicago, IL
¹⁰Roche Products Ltd, Welwyn Garden City, United Kingdom
¹¹Royal Melbourne Hospital, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Australia

Paolo Ghia, MD, PhD¹, Andrzej Pluta, MD^2*, Malgorzata Wach, MD PhD^3*, Daniel Lysak^4*, Tomas Kozak^5*, Martin Šimkovič, MD, PhD^6*, Iryna Kryachok, Prof., PhD^7*, Árpád Illés, MD, PhD^8*, Javier de la Serna^9*, Sean Dolan^10*, Philip Campbell, MBBS¹¹, Gerardo Musuraca, MD, PhD^12*, Abraham Jacob, MD¹³, Eric J. Avery, MD¹⁴, Jae Hoon Lee, MD, PhD¹⁵, Denise Wang^16*, Priti Patel, MD¹⁶ and Wojciech Jurczak^17*

¹Università Vita-Salute San Raffaele and IRCCS Ospedale San Raffaele, Milano, Italy
²Department of Hematological Oncology, Oncology Specialist Hospital, Brzozow, Poland
³Department of Hematooncology and Bone Marrow Transplantation, Medical University of Lublin, Lublin, Poland
⁴Fakultní Nemocnice Plzen, Pilsen, Czech Republic
⁵Fakultní Nemocnice Královske Vinohrady, Prague, Czech Republic
⁶University Hospital Hradec Kralove, Charles University, Hradec Kralove, Czech Republic
⁷National Cancer Institute, Kiev, Ukraine
⁸Faculty of Medicine, Department of Hematology, University of Debrecen, Debrecen, Hungary
⁹Hospital Universitario 12 de Octubre, Madrid, Spain
¹⁰Saint John Regional Hospital, University of New Brunswick, New Brunswick, Canada
¹¹Barwon Health, University Hospital Geelong, Geelong, VIC, Australia
¹²Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola, Italy
¹³The Royal Wolverhampton NHS Trust, Wolverhampton, United Kingdom
¹⁴Nebraska Hematology Oncology, Lincoln, NE
¹⁵Gachon University Gil Medical Center, Incheon, Korea, Republic of (South)
¹⁶Acerta Pharma, South San Francisco, CA
¹⁷Maria Sklodowska-Curie National Institute of Oncology, Krakow, Poland

Jennifer L. Crombie, MD¹, Svitlana Tyekucheva, PhD^2*, Zixu Wang, MS^2*, Alexandra Savell, BS^3*, Lisa Brennan, RN, BSN^3*, Jessica Lowney^3*, Karen Francoeur, RN^4*, Josie Montegaard, NP^3*, Austin I. Kim, MD³, Jacob D. Soumerai, MD⁵, Jon E. Arnason, MD⁶, Allan Louie Cruz, MD^7*, Sigrid Berg, MD⁷, David C. Fisher, MD³, Jennifer R Brown, MD, PhD³ and Matthew S. Davids, MD³

¹Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA
²Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard T.H. Chan School of Public Health, Boston, MA
³Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
⁴Verastem Oncology, Needham, MA
⁵Massachusetts General Hospital, Boston, MA
⁶Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
⁷Northern Light Cancer Care, Brewer, ME

Francesca Romana Mauro, MD, PhD^1*, Gianluigi Reda, MD^2*, Valentina Arena, MS^3*, Livio Trentin, MD⁴, Marta Coscia, MD, PhD^5*, Paolo Sportoletti, MD^6*, Luca Laurenti, MD^7*, Gianluca Gaidano⁸, Roberto Marasca, MD⁹, Lorella Orsucci, MD^10*, Roberta Murru, MD^11*, Caterina Stelitano^12*, Fiorella Ilariucci, MD^13*, Donato Mannina, MD^14*, Massimo Massaia, MD¹⁵, Gian Matteo Rigolin^16*, Lydia Scarfo^17*, Monia Marchetti, MD^18*, Luciano Levato, MD^19*, Monica Tani, MD^20*, Annalisa Arcari, MD^21*, Gerardo Musuraca, MD^22*, Marina Deodato^23*, Piero Galieni^24*, Catello Califano, MD^25*, Daniela Gottardi, MD^26*, Anna Marina Liberati, MD²⁷, Daniela Pietrasanta, MD^28*, Stefano Molica, MD²⁹, Ramona Cassin, MD^30*, Andrea Visentin, MD PhD^31*, Candida Vitale, MD, PhD^32*, Gianfranco Lapietra, MD^33*, Irene Della Starza, PhD^1*, Maria Stefania De Propris, PhD^1*, Sara Raponi, PhD^1*, Mauro Nanni, PhD^1*, Ilaria Del Giudice, MD, PhD^1*, Giorgia Giuliani, PhD^34*, Marco Vignetti, MD^35*, Anna Guarini, PhD^36*, Francesco Albano^37*, Antonino Neri, MD³⁸, Antonio Cuneo, MD^39* and Robin Foà, MD¹

¹Hematology, Department of Translational and Precision Medicine, 'Sapienza' University, Rome, Italy
²Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan, Italy
³GIMEMA Foundation, Rome, Italy
⁴Hematology and Clinical Immunology Unit, Department of Medicine-DIMED, University of Padua, Padua, Italy
⁵Division of Hematology, A.O.U. Città della Salute e della Scienza di Torino and Department of Molecular Biotechnology and Health Sciences, University of Turin, Torino, Italy
⁶Department of Medicine, Division of Hematology and Clinical Immunology, University of Perugia, Perugia, Italy
⁷Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Italy
⁸Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy
⁹Department of Medical and Surgical Sciences, Section of Hematology, University of Modena and Reggio Emilia, Modena, Italy
¹⁰Hematology, Città della Salute Hospital and University, Torino, Italy
¹¹Haematology and Stem Cell Transplantation Unit, Ospedale A. Businco, Cagliari, CAGLIARI, Italy
¹²Azienda Ospedaliera Bianchi-Melacrino-Morelli, Reggio Calabria, RC, ITA
¹³Azienda Ausl IRCCS Santa Maria Nuova Reggio Emilia, Reggio Emilia, Italy
¹⁴UOC di Ematologia, Azienda Ospedaliera Papardo, Messina, ITA
¹⁵Division of Hematology, AO S.Croce e Carle, Cuneo, Italy, Torino, Italy
¹⁶Hematology, St. Anna University Hospital, Cona, Ferrara, Italy
¹⁷Division of Experimental Oncology, Università Vita-Salute San Raffaele and IRCCS Ospedale San Raffaele, Milano, Italy
¹⁸Hematology Day Service, Oncology Unit, Hematology Unit, Az Osp SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy
¹⁹Hematology Unit, A. Pugliese Hospital, Azienda Ospedaliera Pugliese Ciaccio, Catanzaro, Italy
²⁰Unit of Hematology, Santa Maria delle Croci Hospital, Ravenna, Italy
²¹21Hematology Un it, Ospedale Guglielmo da Saliceto, Piacenza, Italy
²²Hematology Unit, IRCCS - Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (I.R.S.T.), Meldola (FC), Italy
²³Department of Hematology, Niguarda Cancer Center, Niguarda Hospital, Milano, Italy
²⁴UOC Ematologia e Terapia Cellulare, Ospedale "C. e G. Mazzoni", Ascoli Piceno, Italy
²⁵U.O. Oncoematologia, P.O. "Andrea Tortora", Pagani, Italy
²⁶Divisione Universitaria di Ematologia e Terapie Cellulari, Divisione Universitaria di Ematologia e Terapie Cellulari, Ospedale Mauriziano Umberto I, Torino, Italy
²⁷Department of Onco-Hematology, University of Perugia, Santa Maria Hospital, Terni, Italy
²⁸Hematology Division, Dipartimento Internistico Struttura complessa di Ematologia Ospedale civile SS Antonio e Biagio, Alessandria, Italy
²⁹Dipartimento Onco-Ematologico, Azienda Ospedaliera Pugliese - Ciaccio, Catanzaro, Italy
³⁰Hematology Department, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milano, Italy
³¹Hematology and Clinical Immunology Unit, Department of Medicine, Hematology and Clinical Immunology Unit, Department of Medicine, University of Padua, Padova, Italy
³²Division of Hematology, A.O.U. Città della Salute e della Scienza di Torino and Department of Molecular Biotechnology and Health Sciences, University of Turin, Torino, TX, Italy
³³Hematology, Department of Translational and Precision Medicine, Sapienza University, Policlinico Umberto I, Roma, Italy
³⁴GIMEMA Foundation, Rome, ITA
³⁵GIMEMA Foundation, Roma, ITA
³⁶Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy
³⁷Hematology and Stem cell Transplantation Unit - Department of Emergency and Organ Transplantation (D.E.T.O.) - University of Bari, Bari, Italy
³⁸BMT Center - Hematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, MI, Italy
³⁹Hematology, Azienda Ospedaliero Universitaria di Ferrara – University of Ferrara, Ferrara, ITA

Eli Muchtar, MD^1*, Amber Koehler, PA-C^1*, Michael J Johnson^2*, Kari G Rabe^3*, Wei Ding, MD, PhD¹, Timothy G. Call, MD¹, Jose F. Leis, MD, PhD⁴, Saad S. Kenderian, MD¹, Suzanne R. Hayman, MD¹, Yucai Wang, MD, PhD⁵, Paul J. Hampel, MD¹, Mathew Holets^6*, Heather C Darby^1*, Susan L. Slager, PhD^3*, Neil E. Kay, MD¹, Jennifer A Whitaker^7*, Myron Levin^8*, Richard Kennedy^6*, Adriana Weinberg^8* and Sameer A. Parikh, MD¹

¹Division of Hematology, Mayo Clinic, Rochester, MN
²University of Colorado ANSCHUTZ MEDICAL CAMPUS, Aurora, CO
³Department of Health Sciences Research, Mayo Clinic, Rochester, MN
⁴Division of Hematology and Medical Oncology, Mayo Clinic Health System, Phoenix, AZ
⁵Division of Hematology, Rutgers New Jersey Medical School, Rochester, MN
⁶Research Services, Mayo Clinic, Rochester, MN
⁷Division of Hematology, Baylor College of Medicine, Houston, TX
⁸University of Colorado ANSCHUTZ MEDICAL, Aurora, CO

Georgios Christopoulos, MD^1*, Zachi I. Attia, PhD^1*, Peter A. Noseworthy, MD^1*, Timothy G. Call, MD², Wei Ding, MD, PhD², Jose F. Leis, MD, PhD³, Eli Muchtar, MD^2*, Saad S. Kenderian, MD², Yucai Wang, MD, PhD⁴, Amber Koehler, PA-C^2*, Neil E. Kay, MD², Prashant Kapoor, MD⁵, Paul A. Friedman, MD^1*, Joerg Herrmann, MD^1* and Sameer A. Parikh, MD²

¹Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN
²Division of Hematology, Mayo Clinic, Rochester, MN
³Division of Hematology and Medical Oncology, Mayo Clinic Health System, Phoenix, AZ
⁴Division of Hematology, Rutgers New Jersey Medical School, Rochester, MN
⁵Mayo Clinic Rochester, Division of Hematology, Rochester, MN

Matthew S. Davids, MD¹, Mazyar Shadman, MD, MPH^2,3*, Sameer A. Parikh, MD⁴, Chaitra S. Ujjani, MD³, Chinheng Chen, BME^5*, Cameron Walsh Johnson^5*, Dingfeng Jiang, MD, PhD^6*, Cynthia Llamas, MS^6*, Dai Feng, PhD^6*, Zaeem Khan, MPH^7* and Nicole Lamanna, MD⁸

¹Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
²Division of Medical Oncology, University of Washington, Seattle, WA
³Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
⁴Division of Hematology, Mayo Clinic, Rochester, MN
⁵Dana-Farber Cancer Institute, Boston, MA
⁶AbbVie Inc., North Chicago, IL
⁷ICON plc, Toronto, ON, Canada
⁸Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY

Jennifer R. Brown, MD, PhD^1*, John C. Byrd, MD², Paolo Ghia, MD, PhD³, Jeff P Sharman, MD⁴, Peter Hillmen, MBChB, PhD, FRCP, FRCPath⁵, Deborah M. Stephens, DO⁶, Clare Sun, MD⁷, Wojciech Jurczak^8*, John M. Pagel, MD PhD⁹, Alessandra Ferrajoli, MD¹⁰, Priti Patel, MD¹¹, Marshall Baek^11*, Tamara Lezhava^11*, Nataliya Kuptsova-Clarkson, MD^12*, Javid J. Moslehi, MD^13* and Richard R. Furman, MD¹⁴

¹Dana-Farber Cancer Institute, Boston, MA
²The Ohio State University Comprehensive Cancer Center, Columbus, OH
³Università Vita-Salute San Raffaele and IRCCS Ospedale San Raffaele, Milano, Italy
⁴Willamette Valley Cancer Institute and US Oncology Research, Eugene, OR
⁵St. James's University Hospital, Leeds, United Kingdom
⁶University of Utah Huntsman Cancer Institute, Salt Lake City, UT
⁷National Heart, Lung, and Blood Institute, Bethesda, MD
⁸Maria Sklodowska-Curie National Institute of Oncology, Krakow, Poland
⁹Center for Blood Disorders and Stem Cell Transplantation, Swedish Cancer Institute, Seattle, WA
¹⁰University of Texas MD Anderson Cancer Center, Houston, TX
¹¹Acerta Pharma, South San Francisco, CA
¹²AstraZeneca, Gaithersburg, MD
¹³Vanderbilt University, Nashville, TN
¹⁴Morton Coleman, M.D. Distinguished Professor of Medicine Weill Cornell Medical College, New York, NY

Alessandra Tedeschi, MD^1*, Anna Maria Frustaci, MD^1*, Francesca Romana Mauro, MD^2*, Annalisa Chiarenza, MD, PhD^3*, Marta Coscia, MD, PhD^4*, Stefania Ciolli⁵, Gianluigi Reda, MD^6*, Luca Laurenti, MD^7*, Marzia Varettoni^8*, Roberta Murru, MD^9*, Claudia Baratè, MD^10*, Paolo Sportoletti, MD^11*, Antonino Greco, MD^12*, Chiara Borella, MD^13*, Valentina Rossi, MD^14*, Marina Deodato, MD^1*, Annalisa Biagi, MD^15*, Angelo Curto Pelle, MD^3*, Gianfranco Lapietra, MD^2*, Candida Vitale, MD, PhD^4*, Francesca Morelli, MD^5*, Ramona Cassin, MD^6*, Alberto Fresa, MD^7*, Elena Flospergher, MD^16*, Massimiliano Postorino, MD^15*, Alessio Di Prima, MD^2*, Roberto Cairoli, MD^1*, Francesco Di Raimondo, MD³, Marco Montillo¹ and Giovanni Del Poeta, MD¹⁵

¹Department of Haematology, Niguarda Cancer Center, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy
²Hematology, Department of Translational and Precision Medicine, Sapienza University, Policlinico Umberto I, Roma, Italy
³Division of Hematology, A.O.U. "Policlinico-Vittorio Emanuele", University of Catania, Catania, Italy
⁴Division of Hematology, A.O.U. Città della Salute e della Scienza di Torino and Department of Molecular Biotechnology and Health Sciences, University of Turin, Torino, Italy
⁵Department of Hematology, Università degli Studi di Firenze, Firenze, Italy
⁶Hematology Department, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milano, Italy
⁷Hematology Institute, Fondazione Policlinico Universitario Agostino Gemelli IRCSS, Roma, Italy
⁸Fondazione IRCCS Policlinico S. Matteo University of Pavia, Pavia, Italy
⁹Haematology and Stem Cell Transplantation Unit, Ospedale A. Businco, Cagliari, CAGLIARI, Italy
¹⁰Department of Clinical and Experimental Medicine, Section of Hematology, University of Pisa, Pisa, Italy
¹¹Department of Medicine, Division of Hematology and Clinical Immunology, University of Perugia, Perugia, Italy
¹²Division of Hematology, Azienda Ospedaliera Giovanni Panìco, Tricase, Italy
¹³Division of Haematology, Ospedale San Gerardo, Monza, Italy
¹⁴Hematology & Transfusion Medicine L. Sacco University Hospital & School of Medicine, Milano, Italy
¹⁵Hematology, Department of Biomedicine and Prevention, University Tor Vergata, Roma, Italy
¹⁶Department of Molecular Medicine, University of Pavia, Pavia, Italy

Maria Dimou, MD, PhD¹, Ioannis Anagnostopoulos, MD^2*, Sotiria Kalyva, PhD^1*, Vasileios Pardalis, MD^1*, Athanasios Markopoulos, PhD^1*, Aikaterini Bitsasni, MD^1*, Theodoros Iliakis, MD^1*, Marie-Christine Kyrtsonis, MD¹ and Panayiotis Panayiotidis, MD¹

¹1st Department of Propedeutic Medicine, Hematology Clinical trials Unit, Laikon General Hospital, Medical School , National and Kapodistrian University of Athens, Athens, Greece
²Medical Diagnostic Center of Flow Cytometry “Phenotypos”, ATHENS, Greece

Max J. Gordon, MD¹, Andy Kaempf, MS^2*, Andrea Sitlinger, MD³, Tareq Salous^4*, Hamood Alqahtani, MBBS^5*, Michael C. Churnetski^6*, Paul Wisniewski, BS^7*, Xavier Issac Rivera, BS^8*, Krish Patel, MD⁷, Daniel O. Persky, MD⁹, Jonathon B. Cohen, MD, MS¹⁰, Michael Y. Choi, MD¹¹, Brian T. Hill, MD¹², Mazyar Shadman, MD¹³, Deborah M. Stephens, DO¹⁴, Danielle M. Brander, MD¹⁵, Byung Park, PhD^16* and Alexey Danilov, MD¹⁷

¹MD Anderson Cancer Center, Houston, TX
²Biostatistics Shared Resource, Knight Cancer Institute, Oregon Health & Science University, Portland, OR
³Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, NC
⁴Cleveland Clinic, Cleveland, OH
⁵Moores Cancer Center at UC San Diego, San Diego, CA
⁶Winship Cancer Institute, Emory University Medical Center, Atlanta, GA
⁷Center for Blood Disorders and Stem Cell Transplantation, Swedish Cancer Institute, Seattle, WA
⁸University of Arizona, Tucson, AZ
⁹Division of Hematology/Oncology, University of Arizona, Tucson, AZ
¹⁰Department of Hematology and Medical Oncology, Emory University, Atlanta, GA
¹¹University of California-San Diego, San Diego, CA
¹²Taussig Cancer Institute, Department of Hematology and Medical Oncology, Cleveland Clinic Foundation, Cleveland, OH
¹³Uw/Fred Hutchinson Cancer Research Center, Seattle, WA
¹⁴University of Utah/Huntsman Cancer Institute, Salt Lake City, UT
¹⁵Duke University, Durham, NC
¹⁶Oregon Health and Science University, Portland, OR
¹⁷Toni Stephenson Lymphoma Center, City of Hope Comprehensive Cancer Center, Duarte, CA

Yucai Wang, MD, PhD¹, Marcella Kaddoura, MD², Sameer A. Parikh, MD³, Timothy G. Call, MD³, Neil E. Kay, MD³, Patrick B. Johnston, MD/ PhD⁴, Luis F. Porrata, MD³, Thomas M. Habermann, MD³, Thomas E. Witzig, MD³, Grzegorz S. Nowakowski, MD³, Stephen M. Ansell, MD, PhD⁵, Min Shi, MD, PhD⁶, Saad S. Kenderian, MD⁷, Eli Muchtar, MD^8*, Suzanne R. Hayman, MD³, Amber B. Koehler, PA-C, MS^3*, Jose F. Leis, MD, PhD⁹ and Wei Ding, MD, PhD³

¹Division of Hematology, Rutgers New Jersey Medical School, Rochester, MN
²Department of Hematology and Medical Oncology, Mayo Clinic, Rochester, MN
³Division of Hematology, Mayo Clinic, Rochester, MN
⁴Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN
⁵Mayo Clinic, Rochester, MN
⁶Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
⁷Department of Immunology, Mayo Clinic, Rochester, MN
⁸Mayo Clinic Rochester, Division of Hematology, Rochester, MN
⁹Division of Hematology and Medical Oncology, Mayo Clinic Health System, Phoenix, AZ

Ian W. Flinn, MD, PhD¹, David Andorsky, MD, PhD^2*, Jason M. Melear, MD³, Sudhir Manda, MD⁴, Bertrand M. Anz III, MD^5*, Kathryn Kolibaba, MD^6*, Habte A. Yimer, MD⁷, John M. Burke, MD⁸, Suzanne R. Fanning, DO⁹, Jay Courtright, MD^10*, Miguel Islas-Ohlmayer, MD^11*, Suman Kambhampati, MD^12*, Daniel Dingfeng Jiang, MD, PhD^13*, John C. Pesko, PhD^13*, Tamas Vizkelety, MD^13*, Simon Sharmokh, MPH, PharmD^13* and Jeff P Sharman, MD¹⁴

¹Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN
²Rocky Mountain Cancer Centers, Boulder, CO
³Texas Oncology-Austin Midtown, Austin, TX
⁴Arizona Oncology/US Oncology Research, Tucson, AZ
⁵Tennessee Oncology, Chattanooga, TN
⁶McKesson Life Sciences, McKesson, The Woodlands, TX
⁷Texas Oncology-Tyler, Tyler, TX
⁸Rocky Mountain Cancer Centers, Aurora, CO
⁹Prisma Health, Greenville, SC
¹⁰Texas Oncology Dallas, Dallas, TX
¹¹Oncology Hematology Care, Inc. Kenwood, Cincinnati, OH
¹²Sarah Cannon Blood Cancer Center at Research Medical Center, Kansas City, MO
¹³AbbVie Inc., North Chicago, IL
¹⁴Willamette Valley Cancer Institute and US Oncology Research, Eugene, OR

Stefano Molica, MD¹, Diana Giannarelli, PhD^2* and Emili Montserrat, MD^3*

¹Dipartimento Onco-Ematologico, Azienda Ospedaliera Pugliese - Ciaccio, Catanzaro, Italy
²Bio-statistical Unit, Regina Elena National Cancer Institute IRCCS, Rome, Italy
³Department of Hematology, Hospital Clinic, University of Barcelona, Barcelona, Spain, Barcelona, Spain